ertapenemhttp://www.unboundmedicine.com/medline/ebm/research/ertapenemUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK.http://www.unboundmedicine.com/medline/ebm/record/19908928/full_citation/Accounting_for_the_Development_of_Antibacterial_Resistance_in_the_Cost_Effectiveness_of_Ertapenem_versus_Piperacillin/Tazobactam_in_the_Treatment_of_Diabetic_Foot_Infections_in_the_UK_Jansen JP, Kumar R, Carmeli Y 
Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK. [Journal Article]
Pharmacoeconomics 2009; 27(12):1045-56.
Abstract | Full CitationAntimicrobial prophylaxis in colorectal surgery: focus on ertapenem.http://www.unboundmedicine.com/medline/ebm/record/19898647/full_citation/Antimicrobial_prophylaxis_in_colorectal_surgery:_focus_on_ertapenem_de Lalla F 
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem. [Journal Article]
Ther Clin Risk Manag 2009.:829-39.
Abstract | Full CitationUnderdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.http://www.unboundmedicine.com/medline/ebm/record/19896806/full_citation/Underdosing_of_ertapenem_in_critically_ill_patients_with_pneumonia_confirmed_by_Monte_Carlo_simulations_Burkhardt O, Kumar V, Schmidt S, et al. 
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. [LETTER]
Int J Antimicrob Agents 2009 Nov 5.
Full CitationIn vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.http://www.unboundmedicine.com/medline/ebm/record/19889520/full_citation/In_vitro_susceptibility_of_Achromobacter_spp__isolates:_comparison_of_disk_diffusion_Etest_and_agar_dilution_methods_Almuzara M, Limansky A, Ballerini V, et al. 
In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Nov 2.
Abstract | Full Citation | Find Related Articles [KPC carbapenemases: What issue in clinical microbiology?]http://www.unboundmedicine.com/medline/ebm/record/19854586/full_citation/[KPC_carbapenemases:_What_issue_in_clinical_microbiology]Cuzon G, Naas T, Nordmann P 
[KPC carbapenemases: What issue in clinical microbiology?] [JOURNAL ARTICLE]
Pathol Biol (Paris) 2009 Oct 23.
Abstract | Full Citation | Find Related Articles [Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?]http://www.unboundmedicine.com/medline/ebm/record/19819496/full_citation/[Treatment_of_community_acquired_pneumonia_in_adults:_ertapenem_versus_cefditoren]Torralba MA, Matía M, Gómez Del Valle C, et al. 
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?] [LETTER]
Med Clin (Barc) 2009 Oct 9.
Full Citation | Find Related Articles Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.http://www.unboundmedicine.com/medline/ebm/record/19800278/full_citation/Refractory_vertebral_osteomyelitis_due_to_CTX_M_14_producing_Escherichia_coli_at_ertapenem_treatment_in_a_patient_with_a_coexisting_urinary_tract_infection_caused_by_the_same_pathogen_Lee CH, Su LH, Lin WC, et al. 
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. [JOURNAL ARTICLE]
Int J Infect Dis 2009 Sep 30.
Abstract | Full CitationIntroduction of ertapenem onto a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa.http://www.unboundmedicine.com/medline/ebm/record/19786596/full_citation/Introduction_of_ertapenem_onto_a_hospital_formulary:_Effect_on_antimicrobial_usage_and_improved_in_vitro_susceptibility_of_Pseudomonas_aeruginosa_Goldstein EJ, Citron DM, Peraino V, et al. 
Introduction of ertapenem onto a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2009 Sep 28.
Abstract | Full Citation | Find Related Articles Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.http://www.unboundmedicine.com/medline/ebm/record/19748427/full_citation/Combination_of_IMP_4_metallo_beta_lactamase_production_and_porin_deficiency_causes_carbapenem_resistance_in_a_Klebsiella_oxytoca_clinical_isolate_Chen LR, Zhou HW, Cai JC, et al. 
Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. [Journal Article]
Diagn Microbiol Infect Dis 2009 Oct; 65(2):163-7.
Abstract | Full Citation | Find Related Articles In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study.http://www.unboundmedicine.com/medline/ebm/record/19748234/full_citation/In_vitro_susceptibilities_of_aerobic_and_facultative_anaerobic_Gram_negative_bacilli_from_patients_with_intra_abdominal_infections_worldwide_from_2005_2007:_results_from_the_SMART_study_Hawser SP, Bouchillon SK, Hoban DJ, et al. 
In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study. [JOURNAL ARTICLE]
Int J Antimicrob Agents 2009 Sep 10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles